Adults with Down syndrome and obstructive sleep apnea treated with hypoglossal nerve stimulation.

IF 3.5 3区 医学 Q1 CLINICAL NEUROLOGY
Phillip Huyett, Stephanie L Santoro, Nicolas M Oreskovic, Brian G Skotko
{"title":"Adults with Down syndrome and obstructive sleep apnea treated with hypoglossal nerve stimulation.","authors":"Phillip Huyett, Stephanie L Santoro, Nicolas M Oreskovic, Brian G Skotko","doi":"10.5664/jcsm.11452","DOIUrl":null,"url":null,"abstract":"<p><strong>Study objectives: </strong>We aimed to examine the feasibility, adherence to therapy, and efficacy of hypoglossal nerve stimulation in adults with Down syndrome and obstructive sleep apnea.</p><p><strong>Methods: </strong>Adults patients with Down syndrome who met criteria for hypoglossal nerve stimulation were prospectively enrolled. Objective adherence was extracted from a cloud-based compliance database. Preoperative sleep studies were compared to follow-up testing performed no sooner than 3 months after device activation.</p><p><strong>Results: </strong>Eleven adults with Down syndrome underwent implantation of hypoglossal nerve stimulation between May 2021 and July 2024. Median age was 27 years (interquartile range 26, 33), body mass index 28.5 kg/m<sup>2</sup> (26.5, 32.4), 27% were female, and patients had severe obstructive sleep apnea (apnea-hypopnea index 40 events/h, 28.4, 42.9). All patients were successfully implanted on an outpatient basis with no postoperative complications or readmissions and activated on schedule at 1 month after surgery. Adherence data show nightly usage longer than 4 hours was 100% and 96% of nights and a median of 9.2 and 8.5 hours/night in the first 30 and 90 days, respectively. Seven patients have undergone follow-up testing and the median entire-night apnea-hypopnea index was reduced by 76%. All patients experienced a > 50% decrease in apnea-hypopnea index and to less than 15 events/h. Median time spent below 88% improved from 2.0% (0.3, 5.0) to 0.2% (0, 0.6), and oxygenation nadir improved from 79.0% (75.5, 85) to 88.0% (86.5, 91).</p><p><strong>Conclusions: </strong>In this small initial cohort, hypoglossal nerve stimulation appears to be a safe, well-tolerated, and efficacious treatment option for adults with Down syndrome with moderate-to-severe obstructive sleep apnea and positive airway pressure therapy intolerance.</p><p><strong>Citation: </strong>Huyett P, Santoro SL, Oreskovic NM, Skotko BG. Adults with Down syndrome and obstructive sleep apnea treated with hypoglossal nerve stimulation. <i>J Clin Sleep Med.</i> 2025;21(4):619-625.</p>","PeriodicalId":50233,"journal":{"name":"Journal of Clinical Sleep Medicine","volume":" ","pages":"619-625"},"PeriodicalIF":3.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11965105/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Sleep Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5664/jcsm.11452","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study objectives: We aimed to examine the feasibility, adherence to therapy, and efficacy of hypoglossal nerve stimulation in adults with Down syndrome and obstructive sleep apnea.

Methods: Adults patients with Down syndrome who met criteria for hypoglossal nerve stimulation were prospectively enrolled. Objective adherence was extracted from a cloud-based compliance database. Preoperative sleep studies were compared to follow-up testing performed no sooner than 3 months after device activation.

Results: Eleven adults with Down syndrome underwent implantation of hypoglossal nerve stimulation between May 2021 and July 2024. Median age was 27 years (interquartile range 26, 33), body mass index 28.5 kg/m2 (26.5, 32.4), 27% were female, and patients had severe obstructive sleep apnea (apnea-hypopnea index 40 events/h, 28.4, 42.9). All patients were successfully implanted on an outpatient basis with no postoperative complications or readmissions and activated on schedule at 1 month after surgery. Adherence data show nightly usage longer than 4 hours was 100% and 96% of nights and a median of 9.2 and 8.5 hours/night in the first 30 and 90 days, respectively. Seven patients have undergone follow-up testing and the median entire-night apnea-hypopnea index was reduced by 76%. All patients experienced a > 50% decrease in apnea-hypopnea index and to less than 15 events/h. Median time spent below 88% improved from 2.0% (0.3, 5.0) to 0.2% (0, 0.6), and oxygenation nadir improved from 79.0% (75.5, 85) to 88.0% (86.5, 91).

Conclusions: In this small initial cohort, hypoglossal nerve stimulation appears to be a safe, well-tolerated, and efficacious treatment option for adults with Down syndrome with moderate-to-severe obstructive sleep apnea and positive airway pressure therapy intolerance.

Citation: Huyett P, Santoro SL, Oreskovic NM, Skotko BG. Adults with Down syndrome and obstructive sleep apnea treated with hypoglossal nerve stimulation. J Clin Sleep Med. 2025;21(4):619-625.

对患有唐氏综合征和阻塞性睡眠呼吸暂停的成人进行舌下神经刺激治疗。
研究目的研究唐氏综合征(DS)成人阻塞性睡眠呼吸暂停患者舌下神经刺激术(HGNS)的可行性、治疗依从性和疗效:符合舌下神经刺激术标准的成年唐氏综合征患者被纳入前瞻性研究。客观依从性从基于云的依从性数据库中提取。将术前睡眠研究与设备激活后 3 个月内进行的随访测试进行比较:11 名患有 DS 的成人在 2021 年 5 月至 2024 年 7 月期间接受了 HGNS 植入手术。中位年龄为 27 岁(四分位距为 26 - 33),体重指数为 28.5kg/m2 (26.5 - 32.4),27% 为女性,患有严重的 OSA(呼吸暂停-低通气指数 (AHI) 40/hr, (28.4 - 42.9))。所有患者均在门诊成功植入,无术后并发症或再入院,术后 1 个月按计划激活。坚持使用的数据显示,在最初的 30 天和 90 天内,每晚使用时间超过 4 小时的比例分别为 100%和 96%,中位数分别为 9.2 小时和 8.5 小时/晚。七名患者接受了后续测试,整晚 AHI 的中位数降低了 76%。所有患者的 AHI 均下降了 50%以上,并降至 15 小时/小时以下。低于88%的中位时间从2.0%(0.3,5.0)减少到0.2%(0,0.6),最低氧饱和度从79.0%(75.5,85)提高到88.0%(86.5,91):对于患有中重度阻塞性睡眠呼吸暂停和气道正压治疗不耐受的 DS 成人来说,HGNS 似乎是一种安全、耐受性好且疗效显著的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
7.00%
发文量
321
审稿时长
1 months
期刊介绍: Journal of Clinical Sleep Medicine focuses on clinical sleep medicine. Its emphasis is publication of papers with direct applicability and/or relevance to the clinical practice of sleep medicine. This includes clinical trials, clinical reviews, clinical commentary and debate, medical economic/practice perspectives, case series and novel/interesting case reports. In addition, the journal will publish proceedings from conferences, workshops and symposia sponsored by the American Academy of Sleep Medicine or other organizations related to improving the practice of sleep medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信